Epidemiologic studies have shown that alcohol plays a pivotal role in the development of osteonecrosis of the femoral head (ONFH). However, few studies have discussed the pathogenesis of or interventions for alcohol-induced ONFH. Objectives: The aim of this study was to explore the underlying mechanism of alcohol-induced ONFH and the protective effect of pifithrin-α (PFTα). Results: Through a series of in vitro assessments, we found that ethanol treatment significantly activated p53, suppressed Wnt/β-catenin signaling and inhibited osteogenic-related proteins, including runt-related transcription factor 2 (RUNX2), osteocalcin (OCN), osteopontin (OPN) and collagen I (COL1). Furthermore, by separating the cytoplasmic and nuclear proteins, we found that ethanol inhibited osteogenesisby impairing the accumulation of β-cateninin both the cytoplasm and nucleus in human bone mesenchymal stem cells (hBMSCs), which resulted from activating glycogen synthase kinase-3β (GSK-3β). In this in vivo study, we established alcohol-induced ONFH in rats and investigated the protective effect of PFTα. Micro-CT, hematoxylin & eosin (H&E) staining, immunohistochemical analyses, immunofluorescence staining, TUNEL staining, and fluorochrome labeling were performed to reveal the PFTα-induced therapeutic effects. H&E findings combined with TUNEL, caspase-3-cleaved immunohistochemical staining, and micro-CT images revealed obvious ONFH in the alcohol-administered rats, whereas significantly less osteonecrosis developed in the rats injected with PFTα. As the initiator of osteogenesis, RUNX2 and its downstream targets OCN, OPN, COL1 were immunostained in the femoral heads. These results indicated that those osteogenic-related proteins were significantly decreased in the alcohol-administered rats, whereas these results were reversed in the PFTα-injected rats. Fluorochrome labeling showed a similar result in that alcohol significantly reduced the osteogenic activity in the rat femoral head, which was blocked by the injection of PFTα. Conclusions: Pifithrin-α, a p53 inhibitor, was able to block the ethanol-triggered activation of p53 in hBMSCs and alcohol-induced ONFH in a rat model. Its antagonistic effect against ethanol's effect on hBMSCs could be a clinical strategy to prevent the development of alcohol-induced ONFH.
AB0064 ADIPOSE STROMAL CELLS EXERT SPECIFIC EFFECTS ON OSTEOARTHRITIC SYNOVIAL MACROPHAGES
Background: Cyclic phosphatidic acid (cPA) is one of bioactive lipid, has been implicated as a mediator of various biological effects including inhibitory effects of proliferation, invasion and metastasis of cancer cells. cPA is naturally occurring mediator even exists in human serum. 2-carba-cPA (2ccPA) is structurally modified formula of cPA and has shown improved bioactivity. We have previously confirmed that 2ccPA stimulated HAS-2 production on human osteoarthritic chondrocytes and synovial fibroblasts (SFs) in vitro. Furthermore, intra-articular administration of 2ccPA has shown its suppressing effect of pain, swelling, and articular cartilage destruction in rabbit experimental osteoarthritis (OA). We have shown that 2ccPA might had direct inhibitory effect of cartilage degrading enzymes on rheumatoid synovial fibroblasts (SFs) in vitro. Inflammatory arthritis such as rheumatoid arthritis (RA) and early stage of OA involves synovial inflammation and subsequent production of cartilage degrading enzymes also from chondrocytes. 2ccPA may be possible another therapeutic option for degenerative arthritis. Objectives: The aim of this study was to evaluate the direct effects of 2ccPA on cartilage matrix degrading enzymes using SFs and articular chondrocytes under influence of inflammatory cytokines.
Methods:
In vitro studies were performed using SFs and chondrocytes obtained from arthritis patients (RA and OA) at joint replacement surgery. First, 2ccPA 0-25 μM was added to cell cultures and effects of 2ccPA on ADAMTS-4, -5, MMP-3, 9, -13 expression was assessed by real time PCR using specific primers to corresponding genes. Beta-actin was used as endogenous expression control for PCR. As we confirmed that 2ccPA had dose-dependent inhibitory effects on expression of above enzymes, the second experiment was performed. SFs or chondrocytes were pre-cultured with IL-1β (1 ng/ml) and/or TNF-α (10 ng/ml) for 24 hours, then added 10 μM 2ccPA to study attenuated effect of 2ccPA on synthesis of above cartilage matrix degrading enzymes. Newly synthesized MMP-3, -13 from SFs or chondrocytes in cultured media after 24 hours of 2ccPA addition were measured by sandwich ELISA. Results: 2ccPA itself repressed cartilage degrading enzymes, ADAMTS-4, ADAMTS-5, MMP-3, MMP-9 and MMP-13 expression in both SFs and chondrocytes was all repressed by low dose of 2ccPA. Even after cells had been stimulated by cytokines, 10 μM 2ccPA repressed expression of cartilage degenerating enzymes in SFs or chondrocytes. Expression of MMP-13 were repressed more in chondrocytes by 2ccPA. ELISA results also confirmed the inhibitory effect of 2ccPA on MMP-13 production in RA SFs (n=5) by 52% or in RA chondrocytes (n=3) by 43%. In OA, MMP-13 production was reduced by 31% in OA SFs (n=6) and 34% in OA chondrocytes (n=4). However, not significant reduction of MMP-3 in both SFs or chondrocytes. MMP-9 expression by ELISA was under the detectable limit.
